Preview

Rational Pharmacotherapy in Cardiology

Advanced search

OPTIMIZATION OF THE TREATMENT OF ELDERLY PATIENTS WITH MYOCARDIAL INFARCTION BY REVASCULARIZATION IN COMBINATION WITH INOTROPIC STIMULATION AND MYOCARDIAL UNLOADING

https://doi.org/10.20996/1819-6446-2008-4-1-27-31

Full Text:

Abstract

Aim. To study effect of coronary revascularization in combination with inotropic stimulation and myocardial unloading on prognosis in elderly patients with myocardial infarction (MI) complicated with heart failure (HF).

Material and methods. 149 elderly patients with ECG picture of acute MI with ST segment elevation and HF symptoms were included into the study. All patients received standard therapy. According to the additional therapeutic maneuvers patients were split into four groups: 18 patients treated with percutaneous transluminal coronary angioplasty (PTCA) combined with inotropic levosimendan (LS) therapy; 20 patients with PTCA only; 22 patients treated with levosimendan (LS) only; control group - 89 patients with standard therapy without PTCA or LS.

Results. Combination of PTCA and LS in elderly patients with acute MI complicated by HF had advantages in comparison with PTCA or LS applied separately or not applied at all. Combined therapy with PTCA and LS resulted in more prominent improvement of left ventricle systolic function, increase in exercise tolerance and more effective prevention of cardiac remodeling and was safe.

Conclusion. Combined therapy with PTCA and LS is more effective than separate usage of these methods in elderly patients with MI complicated with HF.

About the Authors

D. S. Krivonosov
Kemerovo State Medical Academy of Roszdrav. Kemerovo Cardiology Centre
Russian Federation


L. Yu. Chesnokova
Kemerovo State Medical Academy of Roszdrav. Kemerovo Cardiology Centre
Russian Federation


N. I. Tarasov
Kemerovo State Medical Academy of Roszdrav. Kemerovo Cardiology Centre
Russian Federation


References

1. Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. Парадоксы сердечной недостаточности: взгляд на проблему на рубеже веков. Сердечная недостаточность. 2000;1(1):4-7.

2. Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Медикаментозные пути улучшения прогноза больных хронической сердечной недостаточностью. М.: Инсайт. 1997.

3. Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии. М.: ГЭОТАР-Ме- диа. 2006.

4. Беленков Ю.Н., Мареев В.Ю., Скворцов А.А. Левосимендан – новое средство для лечения декомпенсированных больных с тяжелой хронической сердечной недостаточностью. Журнал Сердечная недостаточность. 2004;5(3):3-7.

5. Рябова Т.Р., Рябов В.В. Ремоделирование левого желудочка в ранние и поздние сроки переднего инфаркта миокарда. Патология кровообращения и кардиохирургия. 2001;(4): 65-69.

6. Рябова Т.Р., Соколов А.А., Дудко В.А. и др. Динамика структурных и функциональных показателей левого желудочка у больных острым инфарктом миокарда. Кардиология 2002;(9):30-4.

7. Явелов И.С. Клиническая эффективность сенситизатора кальция – представителя нового класса препаратов с положительным инотропным действием при сердечной недостаточности и инфаркте миокарда. Журнал Сердечная недостаточность. 2005;6(1):33-45.

8. Kersten JR, Montgomery MW., Pagel PS, Warltier DC. Levosimendan, a new positive inotropic drug, decreases myocardial ifarct size via activation of K (ATP) channels. Anesth Analg. 2000;90(1):5-11.

9. Nijland F., Kamp O., Verhorst P.M., et al. Myocardial viability: impact on left ventricular dilatation after acute myocardial infarction. Heart. 2002;87(1):17-22.

10. Narula J., Dawson M.S., Singh B.K. et al. Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy. J Am Coll Cardiol. 2000;36(6):1913-9.


For citation:


Krivonosov D.S., Chesnokova L.Yu., Tarasov N.I. OPTIMIZATION OF THE TREATMENT OF ELDERLY PATIENTS WITH MYOCARDIAL INFARCTION BY REVASCULARIZATION IN COMBINATION WITH INOTROPIC STIMULATION AND MYOCARDIAL UNLOADING. Rational Pharmacotherapy in Cardiology. 2008;4(1):27-31. (In Russ.) https://doi.org/10.20996/1819-6446-2008-4-1-27-31

Views: 288


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)